Jaguar Health (JAGX)
0.60
-0.09 (13.04%)
Upcoming Events
Latest Headlines
Jaguar Health provides crofelemer to infant for compassionate use
September 4, 2026 8:33 AM - StreetInsider
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
September 4, 2026 8:31 AM - StreetInsider
Jaguar Health launches Neonorm Dog for canine digestive support
August 26, 2026 9:01 AM - StreetInsider
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
August 26, 2026 9:01 AM - StreetInsider
Form 424B3 Jaguar Health, Inc.
August 21, 2026 3:01 PM - SEC Filing
Jaguar Health (JAGX) Tops Q2 EPS by 3647c
August 19, 2026 5:25 PM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Aug 19
August 19, 2026 4:15 PM - SEC Filing
Jaguar Health Reports Second Quarter 2026 Financials
August 19, 2026 4:00 PM - StreetInsider
Form 10-Q Jaguar Health, Inc. For: Jun 30
August 19, 2026 1:18 PM - SEC Filing
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
August 18, 2026 9:00 AM - StreetInsider
Form EFFECT Jaguar Health, Inc.
August 17, 2026 6:15 AM - SEC Filing
Form NT 10-Q Jaguar Health, Inc. For: Jun 30
August 14, 2026 5:25 PM - SEC Filing
Form POS AM Jaguar Health, Inc.
August 11, 2026 8:01 AM - SEC Filing
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
August 5, 2026 9:01 AM - StreetInsider
Form DEF 14A Jaguar Health, Inc. For: Sep 04
August 3, 2026 4:37 PM - SEC Filing
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
July 28, 2026 9:01 AM - StreetInsider
Form 424B3 Jaguar Health, Inc.
July 27, 2026 8:01 AM - SEC Filing
Form 424B3 Jaguar Health, Inc.
July 27, 2026 8:00 AM - SEC Filing
Form EFFECT Jaguar Health, Inc.
July 27, 2026 6:03 AM - SEC Filing
Form EFFECT Jaguar Health, Inc.
July 27, 2026 6:03 AM - SEC Filing
Form PRE 14A Jaguar Health, Inc. For: Sep 04
July 24, 2026 4:16 PM - SEC Filing
Jaguar Health (JAGX) files for 41M share offering by selling stockholders
July 24, 2026 2:01 PM - StreetInsider
Form S-1/A Jaguar Health, Inc.
July 24, 2026 1:59 PM - SEC Filing
Jaguar Health expands crofelemer compassionate use to EU infant
July 22, 2026 9:01 AM - StreetInsider
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
July 22, 2026 9:01 AM - StreetInsider
Jaguar Health (JAGX) files for 5.52M share offering by selling stockholders
July 16, 2026 6:04 AM - StreetInsider
Jaguar Health (JAGX) files for 40.8M share offering by selling stockholders
July 16, 2026 6:03 AM - StreetInsider
Form S-1 Jaguar Health, Inc.
July 16, 2026 6:01 AM - SEC Filing
Form S-1 Jaguar Health, Inc.
July 16, 2026 6:01 AM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Jul 09
July 14, 2026 4:15 PM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Jul 01
July 1, 2026 4:34 PM - SEC Filing
Form D Jaguar Health, Inc.
July 1, 2026 6:04 AM - SEC Filing
Form D Jaguar Health, Inc.
July 1, 2026 6:04 AM - SEC Filing
Jaguar Health crofelemer shows PS reductions in pediatric IF patients
June 30, 2026 9:04 AM - StreetInsider
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
June 30, 2026 9:01 AM - StreetInsider
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026 8:35 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 22
June 25, 2026 9:16 AM - SEC Filing
Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
June 25, 2026 9:01 AM - StreetInsider
Jaguar Health files for full FDA approval of dog diarrhea drug
June 23, 2026 9:01 AM - StreetInsider
Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
June 23, 2026 9:01 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - StreetInsider
Form 8-K/A Jaguar Health, Inc. For: Jun 22
June 22, 2026 4:26 PM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Jun 22
June 22, 2026 9:17 AM - SEC Filing
Jaguar Health explores strategic alternatives amid rare disease NDA push
June 22, 2026 9:00 AM - StreetInsider
Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
June 22, 2026 9:00 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 17
June 18, 2026 5:16 PM - SEC Filing
Red Light Holland reports preclinical coca extract results for post-GLP-1 weight management
June 18, 2026 9:03 AM - StreetInsider
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filam
June 18, 2026 9:03 AM - StreetInsider
Magdalena Biosciences coca extract prevents weight gain in mice
June 18, 2026 9:01 AM - StreetInsider
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
June 18, 2026 9:01 AM - StreetInsider
Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
June 12, 2026 9:01 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 08
June 11, 2026 9:01 AM - SEC Filing
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
June 9, 2026 7:00 AM - Globe NewsWire
Form 8-K Jaguar Health, Inc. For: Jun 08
June 8, 2026 4:41 PM - SEC Filing
Jaguar Health reports stockholder approval of all annual meeting proposals
June 8, 2026 4:16 PM - StreetInsider
Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
June 8, 2026 4:15 PM - StreetInsider
Full Article List
